Reclassification of the HPGD p.Ala13Glu variant causing primary hypertrophic osteoarthropathy

Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4):a006291. doi: 10.1101/mcs.a006291. Print 2023 Dec.

Abstract

Here, we highlight the case of a 31-yr-old man who had clinical features of primary hypertrophic osteoarthropathy (PHOAR) and harbored a homozygous variant (c.38C > A, p.Ala13Glu) in the HPGD gene, as indicated by whole-exome sequencing (WES). This variant has been previously classified by our laboratory as a variant of uncertain significance (VUS). However, another patient with the same phenotype and the same homozygous variant in HPGD was subsequently reported. In reassessing the variant, the absence of this variant in the gnomAD population database, supporting computational predictions, observation in homozygosity in two probands, and specificity of the phenotype for HPGD, all provide sufficient evidence to reclassify the HPGD c.38C > A, p.Ala13Glu variant as likely pathogenic.

Keywords: abnormality of the musculature of the limbs.

MeSH terms

  • Exome Sequencing
  • Homozygote
  • Humans
  • Hydroxyprostaglandin Dehydrogenases / genetics
  • Male
  • Osteoarthropathy, Primary Hypertrophic* / diagnosis
  • Osteoarthropathy, Primary Hypertrophic* / genetics
  • Phenotype

Substances

  • Hydroxyprostaglandin Dehydrogenases